Filing Flows

Filing Flows › Innovex International (INVX) › Guidance & outlook

Innovex International (INVX) guidance and outlook

Innovex International (INVX) gave its guidance on Oct 29, 2026: EBITDA $53.0M–$58.0M for Q4 2026. Innovex International's 10-Q filed Nov 4, 2026 makes 13 forward-looking statements.

Guidance and outlook

Innovex International: what its forward-looking statements are about (10-Q filed 2026-11-04)Innovex International: what its forward-looking statements are about (10-Q filed 2026-11-04)Deals4Demand3Other1AI1Financing1Legal & regulation1Margins1People1
13 statements; tone +0.23 (−1 all cautious, +1 all confident); 3 hedged.
Innovex International: outlook statements against the filing beforeInnovex International: outlook statements against the filing beforeConfident4Cautious1

Latest guidance

MetricPeriodRangeChange
EBITDAQ4 2026$53.0M–$58.0Mnew

From the earnings release filed Oct 29, 2026 (8-K on EDGAR).

Forward-looking statements, 10-Q filed Nov 4, 2026

Innovex International's latest quarter

Innovex International, Q3 2026: revenue $265M (+10% year over year), operating margin 12.2%, net earnings $26.3M, operating cash flow $38.8M. The chart follows the revenue to costs, profit and cash.

Questions

Did Innovex International raise or lower its guidance?

Innovex International (INVX) gave its guidance on Oct 29, 2026: EBITDA $53.0M–$58.0M for Q4 2026.

What does Innovex International expect?

We view acquisitions as a core competency and have identified a rich opportunity set of potential targets that we believe are seeking to transact. We aim to pursue high-quality opportunities that meet our stringent investment criteria and align with our long-term growth strategy. Through integrating DIS’ product offering and expertise into our broader platform, we expect to enhance our portfolio of “Big Impact, Small Ticket” products, allowing us to deliver additional value to our global customer base.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.